| mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |
| mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
| mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.05 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.05 |
| mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.05 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.05 |
| mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.05 |